Skip to main content
Fig. 5 | BMC Cardiovascular Disorders

Fig. 5

From: Bone marrow-derived mesenchymal stem cells attenuate myocardial ischemia–reperfusion injury via upregulation of splenic regulatory T cells

Fig. 5

MI area was attenuated by BM-MSCs treatment after MIRI induction. Photographs of TTC stained myocardium tissues of representative MIRI mice treated with IgG, IgG + BM-MSCs, PC61, PC61 + BM-MSCs, splenectomy, and splenectomy + BM-MSCs are shown (a). The hearts were collected 72 h after surgically-induced MIRI. From the micrographs, the area of MI (stained grey by TTC) was calculated and expressed in mean value ± standard deviation of each indicated group (n = 5) (b). BM-MSCs, bone marrow-derived mesenchymal stem cells; MI, myocardial infarction; MIRI, myocardial ischemia–reperfusion injury; TTC, 2,3,5-triphenyltetrazolium

Back to article page